Latest Summit Therapeutics News & Updates

See the latest news and media coverage for Summit Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Summit Therapeutics

Biopharmaceutical company developing investigational oncology therapies

smmttx.com
Headquarters
Miami, United States
Founded year
2003
Company type
Public company
Number of employees
420–500
Industry
Pharmaceuticals

Last updated

Latest news about Summit Therapeutics

In short: Summit Therapeutics received an FDA Complete Response Letter for ivonescimab.

Company announcements

Summit Therapeutics

AstraZeneca invests $2 billion in Summit Therapeutics

Summit enters clinical collaboration for Ivonescimab with AstraZeneca's sonesitatug vedotin and other cancer medicines.

Unlock all announcements with a

Media coverage

RTTNews

A Trio Of FDA Verdicts: BioXcel, Cytokinetics And Summit Await Key Decisions On...

Three biotechnology companies—BioXcel Therapeutics Inc. (BTAI), Cytokinetics Inc. (CYTK) and Summit Therapeutics Inc. (SMMT)— are approaching a major regulatory milestone, with all three scheduled to...

Unlock all articles with a

Never miss news about Summit Therapeutics

Track Summit Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.